]> 2026-08-04T15:45:04+00:00 News 14 en 2007-10-27T08:34:04Z 2454400.8569907 News Today in Medicine: Implanting the Same vs. Different Drug-Eluting Stent (DES) for the Treatment of DES Restenosis. 0 en Today in Medicine: Implanting the Same vs. Different Drug-Eluting Stent (DES) for the Treatment of DES Restenosis. Today in Medicine: Study Shows Favorable Long-Term Outcomes for DES Implantation in Unprotected Left-main Lesions 0 en Today in Medicine: Study Shows Favorable Long-Term Outcomes for DES Implantation in Unprotected Left-main Lesions Wikidoc news template 0 en Wikidoc news template Today in Medicine: Mixed Long-term Results for Sirolimus-Eluting Stent Implantation in Diabetic Patients 0 en Today in Medicine: Mixed Long-term Results for Sirolimus-Eluting Stent Implantation in Diabetic Patients Today in Medicine: Judges or Defendants: Should the Journals be the Judges on Conflict of Interest? 0 en Today in Medicine: Judges or Defendants: Should the Journals be the Judges on Conflict of Interest? June 28, 2007: Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients 0 en June 28, 2007: Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients 0 en Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients Today in Medicine: Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients 0 en Today in Medicine: Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients Today In Medicine: European Heart Journal Announces Articles to be Available in Open Source Format 0 en Today In Medicine: European Heart Journal Announces Articles to be Available in Open Source Format Subendocardial Ischemia In Patients with Chest Pain and Normal Coronary Angiograms: A Cardiovascular Magnetic Resonance Study 0 en Subendocardial Ischemia In Patients with Chest Pain and Normal Coronary Angiograms: A Cardiovascular Magnetic Resonance Study Today in Medicine: SALT study questions prevalence of undiagnosed primary hyperaldosteronism among patients with low-renin hypertension 0 en Today in Medicine: SALT study questions prevalence of undiagnosed primary hyperaldosteronism among patients with low-renin hypertension Hoy en Medicina: El estudio SALT cuestiona la prevalencia de hiperaldosteronismo primario no diagnosticado en pacientes con hipertension y bajos niveles de renina 0 en Hoy en Medicina: El estudio SALT cuestiona la prevalencia de hiperaldosteronismo primario no diagnosticado en pacientes con hipertension y bajos niveles de renina Today in Medicine: NY Times Describes Health and Economic Impact of Ablation for A Fib 0 en Today in Medicine: NY Times Describes Health and Economic Impact of Ablation for A Fib Myeloperoxidase levels shown to predict future cardiovascular risk in healthy individuals. July 11, 2007 0 en Myeloperoxidase levels shown to predict future cardiovascular risk in healthy individuals. July 11, 2007 LV Remodeling Reversed among Patients with Asymptomatic Systolic Dysfunction with Metoprolol 0 en LV Remodeling Reversed among Patients with Asymptomatic Systolic Dysfunction with Metoprolol Genetic risk of atrial fibrillation. July 12, 2007 0 en Genetic risk of atrial fibrillation. July 12, 2007 Hospital-level Mortality Data for MI, CHF Available on Federal Website. June 25, 2007 0 en Hospital-level Mortality Data for MI, CHF Available on Federal Website. June 25, 2007 RNAPc2 in ACS, Results of ANTHEM-TIMI 32. June 22, 2007 0 en RNAPc2 in ACS, Results of ANTHEM-TIMI 32. June 22, 2007 Stents: Johnson & Johnson Reports Significant Decrease in Stent Sales 0 en Stents: Johnson & Johnson Reports Significant Decrease in Stent Sales Glycemic index diets: More lentils, less mushy white bread. July 19, 2007 0 en Glycemic index diets: More lentils, less mushy white bread. July 19, 2007 Periostin: A possible treatment for heart failure. July 20, 2007 0 en Periostin: A possible treatment for heart failure. July 20, 2007 New practice guidelines for use of biomarkers in ACS and heart failure. July 22, 2007 0 en New practice guidelines for use of biomarkers in ACS and heart failure. July 22, 2007 Increased white blood cell count and ventricular remodeling 0 en Increased white blood cell count and ventricular remodeling LDL Cholesterol and its Association with Cancer: July 24, 2007 0 en LDL Cholesterol and its Association with Cancer: July 24, 2007 Metabolic syndrome: Study links soft drink consumption with increased risk of developing metabolic syndrome 0 en Metabolic syndrome: Study links soft drink consumption with increased risk of developing metabolic syndrome Pulmonary embolism is the cause of approximately 10% of hospital deaths despite approved therapies for treatment and prevention. July 26, 2007 0 en Pulmonary embolism is the cause of approximately 10% of hospital deaths despite approved therapies for treatment and prevention. July 26, 2007 Predicting the Mode of Death for Heart Failure Patients. July 29, 2007 0 en Predicting the Mode of Death for Heart Failure Patients. July 29, 2007 Left main coronary artery disease: which stent type is preferred for off-label PCI? 0 en Left main coronary artery disease: which stent type is preferred for off-label PCI? It’s About Time: A Regionalized Approach to Patients with AMI. August 8, 2007 0 en It’s About Time: A Regionalized Approach to Patients with AMI. August 8, 2007 Rosiglitazone: Twists and Turns on the Road to Clarity Regarding Safety with Rosiglitazone. August 10, 2007 0 en Rosiglitazone: Twists and Turns on the Road to Clarity Regarding Safety with Rosiglitazone. August 10, 2007 Loss of adenylyl cyclase gene increases life span and protects the aging heart. August 10th, 2007 0 en Loss of adenylyl cyclase gene increases life span and protects the aging heart. August 10th, 2007 PCI: Nonclinical factors may influence physician decision-making 0 en PCI: Nonclinical factors may influence physician decision-making Understanding the stiff heart: scientists discover the cells and molecules responsible for cardiac fibrosis. August 12, 2007 0 en Understanding the stiff heart: scientists discover the cells and molecules responsible for cardiac fibrosis. August 12, 2007 Reductive stress, like its counterpart oxidative stress, can induce cardiomyopathy. August 16th, 2007 0 en Reductive stress, like its counterpart oxidative stress, can induce cardiomyopathy. August 16th, 2007 Heart failure: A1 Adenosine Antagonists for Heart Failure 0 en Heart failure: A1 Adenosine Antagonists for Heart Failure Heart Failure: Data wanted on Effective Management Strategies for Patients with HF and PSF 0 en Heart Failure: Data wanted on Effective Management Strategies for Patients with HF and PSF Remote ischemic preconditioning may improve clinical outcomes after CABG procedure 0 en Remote ischemic preconditioning may improve clinical outcomes after CABG procedure Long-term outcomes of off-pump vs. on-pump coronary artery bypass grafts. August 12, 2007 0 en Long-term outcomes of off-pump vs. on-pump coronary artery bypass grafts. August 12, 2007 Heart Failure: Acoustic Cardiography Improves Clinicians’ Confidence for Making the Diagnosis when BNP is Ambiguous 0 en Heart Failure: Acoustic Cardiography Improves Clinicians’ Confidence for Making the Diagnosis when BNP is Ambiguous Heart muscle cells grown from human embryonic stem cells can help repair damaged hearts following a heart attack. August 30, 2007 0 en Heart muscle cells grown from human embryonic stem cells can help repair damaged hearts following a heart attack. August 30, 2007 Pre Treatment with 600 mg of Clopidogrel does not Improve Outcomes in Stable PCI Patients: PRAGUE-8 0 en Pre Treatment with 600 mg of Clopidogrel does not Improve Outcomes in Stable PCI Patients: PRAGUE-8 Homocysteine lowering with B vitamins again fails to show benefit 0 en Homocysteine lowering with B vitamins again fails to show benefit Use of Epoetin Alpha in Critically Ill Patients. Sept 10th, 2007. 0 en Use of Epoetin Alpha in Critically Ill Patients. Sept 10th, 2007. Use of Epoetin Alpha in Critically Ill Patients. Sept 8th, 2007. 0 en Use of Epoetin Alpha in Critically Ill Patients. Sept 8th, 2007. Recombinant Human Erythropoietin (rHuEpo): Lack of Effect on Response to ASA or Clopidogrel 0 en Recombinant Human Erythropoietin (rHuEpo): Lack of Effect on Response to ASA or Clopidogrel High Dose Diuretics Associated with Adverse Outcomes in ADHERE 0 en High Dose Diuretics Associated with Adverse Outcomes in ADHERE Heart Failure: Increasing Role of Advanced Practice Nurses in Heart Failure Management 0 en Heart Failure: Increasing Role of Advanced Practice Nurses in Heart Failure Management Venous thromboembolism: Under-recognized and under-treated 0 en Venous thromboembolism: Under-recognized and under-treated Underutilization of Cardiac Rehab Despite Guidelines and Reimbursement 0 en Underutilization of Cardiac Rehab Despite Guidelines and Reimbursement Making the most of cardiac resynchronization therapy : remotely monitoring patients 0 en Making the most of cardiac resynchronization therapy : remotely monitoring patients Ongoing Search for Improved CRT Optimization Technique 0 en Ongoing Search for Improved CRT Optimization Technique States and Institutions Impose Restrictions on Physician-Industry Relationships 0 en States and Institutions Impose Restrictions on Physician-Industry Relationships Panic Attacks in Postmenopausal Women Increase Risk of CV Events 0 en Panic Attacks in Postmenopausal Women Increase Risk of CV Events Study proposes a final common pathway linking smoking, kidney disease, and inflammation to atherogenesis 0 en Study proposes a final common pathway linking smoking, kidney disease, and inflammation to atherogenesis Obesity without insulin resistance: altered fatty acid metabolism in the liver associated with protection from insulin resistance 0 en Obesity without insulin resistance: altered fatty acid metabolism in the liver associated with protection from insulin resistance Guidelines: The ESC/ACC/AHA/WHF Global Task Force Releases New Universal Definition of MI 0 en Guidelines: The ESC/ACC/AHA/WHF Global Task Force Releases New Universal Definition of MI Intravenous iron for treatment of anemia in heart failure 0 en Intravenous iron for treatment of anemia in heart failure Zotarolimus-Eluting stent Non-Inferior to the Paclitaxel-Eluting Stent in Target Vessel Failure, but a Trend Toward Higher Stent Thrombosis is Observed with Zotarolimus: Results of ENDEAVOR 4 Trial 0 en Zotarolimus-Eluting stent Non-Inferior to the Paclitaxel-Eluting Stent in Target Vessel Failure, but a Trend Toward Higher Stent Thrombosis is Observed with Zotarolimus: Results of ENDEAVOR 4 Trial Western Denmark Registry demonstrates lower risk of thrombosis for Cypher stent 0 en Western Denmark Registry demonstrates lower risk of thrombosis for Cypher stent XIENCE V One Year Data Presented at TCT 2007 0 en XIENCE V One Year Data Presented at TCT 2007 VEGF-165 Plasmid Gene Therapy in Patients with Refractory Angina Fails to Improve Outcomes in the Northern Trial 0 en VEGF-165 Plasmid Gene Therapy in Patients with Refractory Angina Fails to Improve Outcomes in the Northern Trial New guidelines hope to clarify the role of endomyocardial biopsies 0 en New guidelines hope to clarify the role of endomyocardial biopsies Heart Failure: Results of CORONA trial released 0 en Heart Failure: Results of CORONA trial released Statins in Heart Failure: Results of CORONA 0 en Statins in Heart Failure: Results of CORONA Torcetrapib Associated with Higher CV Event Rates in ILLUMINATE 0 en Torcetrapib Associated with Higher CV Event Rates in ILLUMINATE Prevention: Results of the ILLUMINATE Trial Released at AHA 2007 0 en Prevention: Results of the ILLUMINATE Trial Released at AHA 2007 SPECT Substudy of COURAGE shows Improved Perfusion with PCI at Follow-Up 0 en SPECT Substudy of COURAGE shows Improved Perfusion with PCI at Follow-Up PROVIDENCE-1 trial Results: Rifalazil Has No Effect in Patients with Intermittent Claudication 0 en PROVIDENCE-1 trial Results: Rifalazil Has No Effect in Patients with Intermittent Claudication The Couma-Gen Study did not Demonstrate a Reduction in Out-of-range INRs in Patients with Pharmacogenetic-guided Dosing of Warfarin 0 en The Couma-Gen Study did not Demonstrate a Reduction in Out-of-range INRs in Patients with Pharmacogenetic-guided Dosing of Warfarin Results from STITCH Trial Demonstrate a Simplified, Step-Care Process is More Effective than Guidelines-Based Practice in Hypertension Treatment 0 en Results from STITCH Trial Demonstrate a Simplified, Step-Care Process is More Effective than Guidelines-Based Practice in Hypertension Treatment Metoprolol Associated with Lower Rates of Major CV Events in POISE Trial for High Risk Patients Undergoing Noncardiac Surgery 0 en Metoprolol Associated with Lower Rates of Major CV Events in POISE Trial for High Risk Patients Undergoing Noncardiac Surgery Microvolt T Wave Alternans Test (MTWA) not Predictive of Ventricular Arrhythias Following MI 0 en Microvolt T Wave Alternans Test (MTWA) not Predictive of Ventricular Arrhythias Following MI Rhythm Control Demonstrated as Equally Effective as Rate Control in Preventing CV Mortality 0 en Rhythm Control Demonstrated as Equally Effective as Rate Control in Preventing CV Mortality Rethinking a “healthy weight”: New study finds that being overweight is not associated with increased mortality from cardiovascular causes 0 en Rethinking a “healthy weight”: New study finds that being overweight is not associated with increased mortality from cardiovascular causes Tirofiban and transfer compares favorably to fibrinolysis in STEMI 0 en Tirofiban and transfer compares favorably to fibrinolysis in STEMI More evidence of the primacy of chest compressions over ventilation in cardiopulmonary resuscitation 0 en More evidence of the primacy of chest compressions over ventilation in cardiopulmonary resuscitation Statins found to be protective against recurrence of atrial fibrillation after cardioversion 0 en Statins found to be protective against recurrence of atrial fibrillation after cardioversion Viagra for failing hearts 0 en Viagra for failing hearts JNK in the trunk without extra sugar in the tank 0 en JNK in the trunk without extra sugar in the tank Treatment of paroxysmal nocturnal hemoglobinuria with the anti-complement antibody eculizumab helps prevent thromboembolism 0 en Treatment of paroxysmal nocturnal hemoglobinuria with the anti-complement antibody eculizumab helps prevent thromboembolism New meta-analysis demonstrates significant incidence of psychiatric side effects of the weight loss medication rimonabant 0 en New meta-analysis demonstrates significant incidence of psychiatric side effects of the weight loss medication rimonabant Lancet Editor Forsees Wikis as the Future for Medical Journals 0 en Lancet Editor Forsees Wikis as the Future for Medical Journals The safety of thiazolidinediones in older diabetics 0 en The safety of thiazolidinediones in older diabetics Sunitinib, a small molecular weight tyrosine-kinase inhibitor, is found to have cardiac toxicity 0 en Sunitinib, a small molecular weight tyrosine-kinase inhibitor, is found to have cardiac toxicity New target for treating salt-induced hypertension 0 en New target for treating salt-induced hypertension Statins may cause sleep disorders 0 en Statins may cause sleep disorders Renin: who needs it, anyway? 0 en Renin: who needs it, anyway? How do I submit news article 0 en How do I submit news article Nephrotic syndrome and risk of venous and arterial thromboembolism 0 en Nephrotic syndrome and risk of venous and arterial thromboembolism New formula for predicting long-term survival based on exercise treadmill testing 0 en New formula for predicting long-term survival based on exercise treadmill testing Planning your New Year’s resolution—which diet is best? 0 en Planning your New Year’s resolution—which diet is best? Preoperative statins for prevention of atrial fibrillation following cardiac surgery 0 en Preoperative statins for prevention of atrial fibrillation following cardiac surgery “Renal-dose” dopamine increases renal blood flow in heart failure patients 0 en “Renal-dose” dopamine increases renal blood flow in heart failure patients High red cell distribution width associated with adverse outcomes in patients with coronary artery disease 0 en High red cell distribution width associated with adverse outcomes in patients with coronary artery disease In vivo imaging of inflammatory cells trafficking to atherosclerotic lesions 0 en In vivo imaging of inflammatory cells trafficking to atherosclerotic lesions Vitamin D deficiency associated with cardiovascular risk 0 en Vitamin D deficiency associated with cardiovascular risk New AHA statement focuses on improving rates and success of bystander CPR 0 en New AHA statement focuses on improving rates and success of bystander CPR Inflammatory biomarkers predict short-term mortality in patients with peripheral arterial disease 0 en Inflammatory biomarkers predict short-term mortality in patients with peripheral arterial disease New randomized comparison of unprotected left main coronary artery stenting and CABG 0 en New randomized comparison of unprotected left main coronary artery stenting and CABG NHLBI recommends early termination of the intensive blood sugar lowering strategy in the ACCORD trial 0 en NHLBI recommends early termination of the intensive blood sugar lowering strategy in the ACCORD trial Paclitaxel eluting stents are safe and effective in diabetic patients compared to bare metal stents 0 en Paclitaxel eluting stents are safe and effective in diabetic patients compared to bare metal stents Intensive blood sugar control among diabetics does not increase mortality in the ADVANCE trial 0 en Intensive blood sugar control among diabetics does not increase mortality in the ADVANCE trial Paclitaxel coated angioplasty balloons are effective in reducing restenosis in the leg 0 en Paclitaxel coated angioplasty balloons are effective in reducing restenosis in the leg Immediate transfer for PCI after fibrinolysis plus abciximab improves outcome in CARESS-in-AMI trial 0 en Immediate transfer for PCI after fibrinolysis plus abciximab improves outcome in CARESS-in-AMI trial Metabolic syndrome linked to higher rates of atrial fibrillation 0 en Metabolic syndrome linked to higher rates of atrial fibrillation MC-1 does not reduce cardiovascular and cerebrovascular events in phase 3 MEND-CABG II trial 0 en MC-1 does not reduce cardiovascular and cerebrovascular events in phase 3 MEND-CABG II trial MC-1 does not reduce cardiovascular and cerebrovascular events in the phase 3 MEND-CABG II trial 0 en MC-1 does not reduce cardiovascular and cerebrovascular events in the phase 3 MEND-CABG II trial New AHA statement on hyperglycemia during ACS admissions 0 en New AHA statement on hyperglycemia during ACS admissions Genetic variability is linked to differences in response to warfarin therapy 0 en Genetic variability is linked to differences in response to warfarin therapy Promising results from a phase 2 study of a vaccine for hypertension 0 en Promising results from a phase 2 study of a vaccine for hypertension Transfusion of blood stored for more than 14 days increases mortality among cardiac surgical patients 0 en Transfusion of blood stored for more than 14 days increases mortality among cardiac surgical patients New guidelines for the management of cocaine chest pain 0 en New guidelines for the management of cocaine chest pain New study uses gene variants to predict cardiovascular risk 0 en New study uses gene variants to predict cardiovascular risk TRITON-TIMI 38 stent analysis demonstrates that prasugrel is better than clopidogrel in reducing the incidence of early and late stent thrombosis 0 en TRITON-TIMI 38 stent analysis demonstrates that prasugrel is better than clopidogrel in reducing the incidence of early and late stent thrombosis Platelet monitoring can improve outcomes following PCI among clopidogrel resistant patients 0 en Platelet monitoring can improve outcomes following PCI among clopidogrel resistant patients Percutaneous Coronary Interventions can be performed in centers without on-site cardiac surgical back-up 0 en Percutaneous Coronary Interventions can be performed in centers without on-site cardiac surgical back-up High recurrence rate of stent thrombosis after the first event: Results from the Dutch Stent Thrombosis Registry 0 en High recurrence rate of stent thrombosis after the first event: Results from the Dutch Stent Thrombosis Registry Removal of debris from the coronary arteries does not improve outcomes: Results from the A-F study 0 en Removal of debris from the coronary arteries does not improve outcomes: Results from the A-F study Thrombus aspiration in patients with ST elevation myocardial infarction improves mortality at 1 year in the TAPAS trial 0 en Thrombus aspiration in patients with ST elevation myocardial infarction improves mortality at 1 year in the TAPAS trial High Dose Tirofiban is similar to Abciximab in reducing Major Adverse Cardiac Events 0 en High Dose Tirofiban is similar to Abciximab in reducing Major Adverse Cardiac Events Left main stenting is associated with similar rates of death, Q wave myocardial infarction and stroke compared with CABG at 3-year follow-up 0 en Left main stenting is associated with similar rates of death, Q wave myocardial infarction and stroke compared with CABG at 3-year follow-up Long Term Adherence to Clopidogrel and Late Adverse Cardiac Events after Off-Label Use of Sirolimus-Eluting Stents: Results of the MATRIX Registry 0 en Long Term Adherence to Clopidogrel and Late Adverse Cardiac Events after Off-Label Use of Sirolimus-Eluting Stents: Results of the MATRIX Registry PEPCAD II ISR study suggests that drug eluting balloons are safe and effective compared with drug eluting stents in treating in-stent restenosis 0 en PEPCAD II ISR study suggests that drug eluting balloons are safe and effective compared with drug eluting stents in treating in-stent restenosis The GENESIS Trial Demonstrates Disappointing Results With Pimecrolimus Eluting Stents 0 en The GENESIS Trial Demonstrates Disappointing Results With Pimecrolimus Eluting Stents The Efficacy of XIENCE V Stent over Taxus Stent Decreases with Time: Results from the SPIRIT II study 0 en The Efficacy of XIENCE V Stent over Taxus Stent Decreases with Time: Results from the SPIRIT II study Telmisartan is as effective and safe as ramipril in patients at high risk for vascular events: Results from the ONTARGET trial 0 en Telmisartan is as effective and safe as ramipril in patients at high risk for vascular events: Results from the ONTARGET trial Treatment of hypertension with indapamide with or without perindopril is beneficial in the elderly: Results from the HYVET study 0 en Treatment of hypertension with indapamide with or without perindopril is beneficial in the elderly: Results from the HYVET study Rosuvastatin reduces coronary artery disease progression over time in the ASTEROID trial 0 en Rosuvastatin reduces coronary artery disease progression over time in the ASTEROID trial Pioglitazone Prevents Progression of Coronary Atherosclerosis in Diabetic Patients With Coronary Artery Disease: Results of the PERISCOPE Trial 0 en Pioglitazone Prevents Progression of Coronary Atherosclerosis in Diabetic Patients With Coronary Artery Disease: Results of the PERISCOPE Trial Rimonabant does not reduce atherosclerosis progression in STRADIVARIUS 0 en Rimonabant does not reduce atherosclerosis progression in STRADIVARIUS Insertable Loop Recorder Tracks Cardiac Arrhythmias Following Acute Myocardial Infarction 0 en Insertable Loop Recorder Tracks Cardiac Arrhythmias Following Acute Myocardial Infarction The EVEREST trial suggests MitraClip® for mitral regurgitation is effective 0 en The EVEREST trial suggests MitraClip® for mitral regurgitation is effective Similar nephrotoxic effects with iodixanol and iomeprol in the CONTRAST trial 0 en Similar nephrotoxic effects with iodixanol and iomeprol in the CONTRAST trial Standard Physician Care for Heart Failure is Just as Effective as and Less Expensive Than a Home Monitoring System 0 en Standard Physician Care for Heart Failure is Just as Effective as and Less Expensive Than a Home Monitoring System The ASTRAL Trial Demonstrates Angioplasty and Stenting Offer No Benefit Over Medical Therapy in Patients with Renal Arterial Stenoses 0 en The ASTRAL Trial Demonstrates Angioplasty and Stenting Offer No Benefit Over Medical Therapy in Patients with Renal Arterial Stenoses MEND-CABG II trial does not suggest improved outcomes with the novel drug MC1 in patients undergoing high risk coronary artery bypass surgery 0 en MEND-CABG II trial does not suggest improved outcomes with the novel drug MC1 in patients undergoing high risk coronary artery bypass surgery Reloading With Clopidogrel Improves Clinical Outcomes in Patients with Acute Coronary Syndromes: ARMYDA-RELOAD 0 en Reloading With Clopidogrel Improves Clinical Outcomes in Patients with Acute Coronary Syndromes: ARMYDA-RELOAD Implantation of skeletal myoblasts into scarred myocardium improves symptoms but not heart function 0 en Implantation of skeletal myoblasts into scarred myocardium improves symptoms but not heart function High dose tirofiban and clopidogrel are safe and effective in the ON-TIME-2 trial 0 en High dose tirofiban and clopidogrel are safe and effective in the ON-TIME-2 trial WikiDoc News: Stories Submitted for Publication 0 en WikiDoc News: Stories Submitted for Publication Treatment of hypertension in the very old reduces all-cause mortality 0 en Treatment of hypertension in the very old reduces all-cause mortality Predicting who will benefit from cardiac resynchronization therapy: results of PROSPECT 0 en Predicting who will benefit from cardiac resynchronization therapy: results of PROSPECT The 2009 SCAI Annual Scientific Sessions is to be held in Las Vegas 0 en The 2009 SCAI Annual Scientific Sessions is to be held in Las Vegas NOBORI™ stent is non-inferior to Taxus® stents in the NOBORI 1 trial 0 en NOBORI™ stent is non-inferior to Taxus® stents in the NOBORI 1 trial Xience V stent continues to demonstrate superior efficacy over the Taxus stent up to 2 years in the SPIRIT III trial 0 en Xience V stent continues to demonstrate superior efficacy over the Taxus stent up to 2 years in the SPIRIT III trial Landmark analysis of the TRITON-TIMI 38 trial demonstrates significant benefit with the loading and maintenance doses of prasugrel 0 en Landmark analysis of the TRITON-TIMI 38 trial demonstrates significant benefit with the loading and maintenance doses of prasugrel PRoFESS®, the Largest Recurrent Stroke Prevention Trial Results were Presented at the 17th European Stroke Conference 0 en PRoFESS®, the Largest Recurrent Stroke Prevention Trial Results were Presented at the 17th European Stroke Conference Time to Abandon Facilitated PCI: Results from the FINESSE trial 0 en Time to Abandon Facilitated PCI: Results from the FINESSE trial Gradual decline in mortality rate following STEMI in the United States 0 en Gradual decline in mortality rate following STEMI in the United States Upstream Pharmacotherapy not Superior to Cath Lab Based Therapy in Primary PCI: Results from the FINESSE Trial 0 en Upstream Pharmacotherapy not Superior to Cath Lab Based Therapy in Primary PCI: Results from the FINESSE Trial Pre-operative Statin Therapy Improves Clinical Outcomes among Cardiac Surgical Patients: Results from a Meta-Analysis 0 en Pre-operative Statin Therapy Improves Clinical Outcomes among Cardiac Surgical Patients: Results from a Meta-Analysis One third of deaths following coronary artery bypass surgery are preventable 0 en One third of deaths following coronary artery bypass surgery are preventable Intensive blood sugar control is associated with increased mortality among type 2 diabetics in ACCORD 0 en Intensive blood sugar control is associated with increased mortality among type 2 diabetics in ACCORD Successful PCI for Chronic Total Occlusion of the LAD is Associated with Improved Long-term Survival 0 en Successful PCI for Chronic Total Occlusion of the LAD is Associated with Improved Long-term Survival Rhythm control is no better than rate control among patients with atrial fibrillation and congestive heart failure 0 en Rhythm control is no better than rate control among patients with atrial fibrillation and congestive heart failure Intracoronary abciximab is superior to intravenous infusion in reducing infarct size during primary PCI 0 en Intracoronary abciximab is superior to intravenous infusion in reducing infarct size during primary PCI Low-risk Women with Unstable Angina and NSTEMI Might be Better off with Medical Therapy than Invasive Treatment 0 en Low-risk Women with Unstable Angina and NSTEMI Might be Better off with Medical Therapy than Invasive Treatment Simvastatin and ezetimibe combination does not reduce the rate of progression of aortic valve disease in the SEAS trial 0 en Simvastatin and ezetimibe combination does not reduce the rate of progression of aortic valve disease in the SEAS trial Larger Versus Smaller Clinical Safety Databases for Regulatory Approval of Drugs. 0 en Larger Versus Smaller Clinical Safety Databases for Regulatory Approval of Drugs. The On-Time 2 trial Suggests Benefit with Early Administration of Tirofiban in the Ambulance following Acute Myocardial Infarction. 0 en The On-Time 2 trial Suggests Benefit with Early Administration of Tirofiban in the Ambulance following Acute Myocardial Infarction. TRANSCEND Study suggests that telmisartan reduces cardiovascular events 0 en TRANSCEND Study suggests that telmisartan reduces cardiovascular events The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients 0 en The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients Rosuvastatin is Not Beneficial Among Patients with Chronic Heart Failure: Results from GISSI-HF trial 0 en Rosuvastatin is Not Beneficial Among Patients with Chronic Heart Failure: Results from GISSI-HF trial TRANSCEND Study Misses Primary Endpoint 0 en TRANSCEND Study Misses Primary Endpoint Intensified NT BNPguided Therapy might be Beneficial among Patients aged less than 75 Years: Results from the TIME-CHF Trial 0 en Intensified NT BNPguided Therapy might be Beneficial among Patients aged less than 75 Years: Results from the TIME-CHF Trial Revascularization with CABG or PCI had no Difference on Outcomes of Death, non-fatal MI, or CVA for Diabetics with Multi-Vessel Coronary Disease: Results of the CARDia Trial 0 en Revascularization with CABG or PCI had no Difference on Outcomes of Death, non-fatal MI, or CVA for Diabetics with Multi-Vessel Coronary Disease: Results of the CARDia Trial SYNTAX study fails to support PCI as non-inferior to CABG in patients with left main or 3-vessel coronary artery disease 0 en SYNTAX study fails to support PCI as non-inferior to CABG in patients with left main or 3-vessel coronary artery disease HDB Tirofiban decreases rate of periprocedural myocardial infarction compared to placebo in patients with poor responsiveness to clopidogrel and aspirin: Results of the 3T/2R study 0 en HDB Tirofiban decreases rate of periprocedural myocardial infarction compared to placebo in patients with poor responsiveness to clopidogrel and aspirin: Results of the 3T/2R study High dose Tirofiban Might be Beneficial among Poor Responders to Clopidogrel and Aspirin Following Elective PCI: Results of the 3T/2R study 0 en High dose Tirofiban Might be Beneficial among Poor Responders to Clopidogrel and Aspirin Following Elective PCI: Results of the 3T/2R study Intracoronary infusion of selected and unselected mononuclear cells does not lead to significant improvement in cardiac function after sustained ischemia: Results from the REGENT trial 0 en Intracoronary infusion of selected and unselected mononuclear cells does not lead to significant improvement in cardiac function after sustained ischemia: Results from the REGENT trial Should beta-Blockers Be Continued for Patients Hospitalized with decompenstated Heart Failure 0 en Should beta-Blockers Be Continued for Patients Hospitalized with decompenstated Heart Failure Inhaled anticholinergics for the treatment of COPD is associated with an increased risk of cardiovascular events. 0 en Inhaled anticholinergics for the treatment of COPD is associated with an increased risk of cardiovascular events. JUPITER Trial Demonstrates Effectiveness of Statin Therapy in Reducing Cardiovascular Events among Healthy Patients 0 en JUPITER Trial Demonstrates Effectiveness of Statin Therapy in Reducing Cardiovascular Events among Healthy Patients Susceptibility loci for intracranial aneurysm in European and Japanese populations 0 en Susceptibility loci for intracranial aneurysm in European and Japanese populations Measuring Fractional Flow Reserve During PCI Improves 1-Year Outcomes 0 en Measuring Fractional Flow Reserve During PCI Improves 1-Year Outcomes Double dose Clopidogrel associated with improved cardiac outcomes in patients undergoing PCI: Results of CURRENT/OASIS-7 Trial 0 en Double dose Clopidogrel associated with improved cardiac outcomes in patients undergoing PCI: Results of CURRENT/OASIS-7 Trial Dabigatran is non-inferior to warfarin in patients with atrial fibrillation: Results of the RE-LY trial 0 en Dabigatran is non-inferior to warfarin in patients with atrial fibrillation: Results of the RE-LY trial Ticagrelor is superior to Clopidogrel in the treatment of patients with acute coronary syndrome with or without ST-segment elevation: Results of the PLATO study 0 en Ticagrelor is superior to Clopidogrel in the treatment of patients with acute coronary syndrome with or without ST-segment elevation: Results of the PLATO study Anti-restenotic efficacy of SES is non-superior to PES in patients with SES-restenosis: Results of the ISAR-DESIRE 2 Trial 0 en Anti-restenotic efficacy of SES is non-superior to PES in patients with SES-restenosis: Results of the ISAR-DESIRE 2 Trial Anti-restenotic efficacy of SES is non-superior to PES in patients with SES-restenosis: Results of the ISAR-DESIRE 2 Trial 0 en Anti-restenotic efficacy of SES is non-superior to PES in patients with SES-restenosis: Results of the ISAR-DESIRE 2 Trial Dabigatran is non-inferior to warfarin in patients with atrial fibrillation: Results of the RE-LY trial 0 en Dabigatran is non-inferior to warfarin in patients with atrial fibrillation: Results of the RE-LY trial Double dose Clopidogrel associated with improved cardiac outcomes in patients undergoing PCI: Results of CURRENT/OASIS-7 Trial 0 en Double dose Clopidogrel associated with improved cardiac outcomes in patients undergoing PCI: Results of CURRENT/OASIS-7 Trial Genetic risk of atrial fibrillation. July 12, 2007 0 en Genetic risk of atrial fibrillation. July 12, 2007 Genetic variability is linked to differences in response to warfarin therapy 0 en Genetic variability is linked to differences in response to warfarin therapy Glycemic index diets: More lentils, less mushy white bread. July 19, 2007 0 en Glycemic index diets: More lentils, less mushy white bread. July 19, 2007 Gradual decline in mortality rate following STEMI in the United States 0 en Gradual decline in mortality rate following STEMI in the United States Guidelines: The ESC/ACC/AHA/WHF Global Task Force Releases New Universal Definition of MI 0 en Guidelines: The ESC/ACC/AHA/WHF Global Task Force Releases New Universal Definition of MI HDB Tirofiban decreases rate of periprocedural myocardial infarction compared to placebo in patients with poor responsiveness to clopidogrel and aspirin: Results of the 3T/2R study 0 en HDB Tirofiban decreases rate of periprocedural myocardial infarction compared to placebo in patients with poor responsiveness to clopidogrel and aspirin: Results of the 3T/2R study Heart Failure: Acoustic Cardiography Improves Clinicians’ Confidence for Making the Diagnosis when BNP is Ambiguous 0 en Heart Failure: Acoustic Cardiography Improves Clinicians’ Confidence for Making the Diagnosis when BNP is Ambiguous Heart Failure: Data wanted on Effective Management Strategies for Patients with HF and PSF 0 en Heart Failure: Data wanted on Effective Management Strategies for Patients with HF and PSF Heart Failure: Increasing Role of Advanced Practice Nurses in Heart Failure Management 0 en Heart Failure: Increasing Role of Advanced Practice Nurses in Heart Failure Management Heart Failure: Results of CORONA trial released 0 en Heart Failure: Results of CORONA trial released Heart failure: A1 Adenosine Antagonists for Heart Failure 0 en Heart failure: A1 Adenosine Antagonists for Heart Failure Heart muscle cells grown from human embryonic stem cells can help repair damaged hearts following a heart attack. August 30, 2007 0 en Heart muscle cells grown from human embryonic stem cells can help repair damaged hearts following a heart attack. August 30, 2007 High Dose Diuretics Associated with Adverse Outcomes in ADHERE 0 en High Dose Diuretics Associated with Adverse Outcomes in ADHERE High Dose Tirofiban is similar to Abciximab in reducing Major Adverse Cardiac Events 0 en High Dose Tirofiban is similar to Abciximab in reducing Major Adverse Cardiac Events High dose Tirofiban Might be Beneficial among Poor Responders to Clopidogrel and Aspirin Following Elective PCI: Results of the 3T/2R study 0 en High dose Tirofiban Might be Beneficial among Poor Responders to Clopidogrel and Aspirin Following Elective PCI: Results of the 3T/2R study High dose tirofiban and clopidogrel are safe and effective in the ON-TIME-2 trial 0 en High dose tirofiban and clopidogrel are safe and effective in the ON-TIME-2 trial High recurrence rate of stent thrombosis after the first event: Results from the Dutch Stent Thrombosis Registry 0 en High recurrence rate of stent thrombosis after the first event: Results from the Dutch Stent Thrombosis Registry High red cell distribution width associated with adverse outcomes in patients with coronary artery disease 0 en High red cell distribution width associated with adverse outcomes in patients with coronary artery disease Homocysteine lowering with B vitamins again fails to show benefit 0 en Homocysteine lowering with B vitamins again fails to show benefit Hospital-level Mortality Data for MI, CHF Available on Federal Website. June 25, 2007 0 en Hospital-level Mortality Data for MI, CHF Available on Federal Website. June 25, 2007 How do I submit news article 0 en How do I submit news article Hoy en Medicina: El estudio SALT cuestiona la prevalencia de hiperaldosteronismo primario no diagnosticado en pacientes con hipertension y bajos niveles de renina 0 en Hoy en Medicina: El estudio SALT cuestiona la prevalencia de hiperaldosteronismo primario no diagnosticado en pacientes con hipertension y bajos niveles de renina Immediate transfer for PCI after fibrinolysis plus abciximab improves outcome in CARESS-in-AMI trial 0 en Immediate transfer for PCI after fibrinolysis plus abciximab improves outcome in CARESS-in-AMI trial Implantation of skeletal myoblasts into scarred myocardium improves symptoms but not heart function 0 en Implantation of skeletal myoblasts into scarred myocardium improves symptoms but not heart function In vivo imaging of inflammatory cells trafficking to atherosclerotic lesions 0 en In vivo imaging of inflammatory cells trafficking to atherosclerotic lesions Increased white blood cell count and ventricular remodeling 0 en Increased white blood cell count and ventricular remodeling Inflammatory biomarkers predict short-term mortality in patients with peripheral arterial disease 0 en Inflammatory biomarkers predict short-term mortality in patients with peripheral arterial disease Inhaled anticholinergics for the treatment of COPD is associated with an increased risk of cardiovascular events. 0 en Inhaled anticholinergics for the treatment of COPD is associated with an increased risk of cardiovascular events. Insertable Loop Recorder Tracks Cardiac Arrhythmias Following Acute Myocardial Infarction 0 en Insertable Loop Recorder Tracks Cardiac Arrhythmias Following Acute Myocardial Infarction Intensified NT BNPguided Therapy might be Beneficial among Patients aged less than 75 Years: Results from the TIME-CHF Trial 0 en Intensified NT BNPguided Therapy might be Beneficial among Patients aged less than 75 Years: Results from the TIME-CHF Trial Intensive blood sugar control among diabetics does not increase mortality in the ADVANCE trial 0 en Intensive blood sugar control among diabetics does not increase mortality in the ADVANCE trial Intensive blood sugar control is associated with increased mortality among type 2 diabetics in ACCORD 0 en Intensive blood sugar control is associated with increased mortality among type 2 diabetics in ACCORD Intracoronary abciximab is superior to intravenous infusion in reducing infarct size during primary PCI 0 en Intracoronary abciximab is superior to intravenous infusion in reducing infarct size during primary PCI Intracoronary infusion of selected and unselected mononuclear cells does not lead to significant improvement in cardiac function after sustained ischemia: Results from the REGENT trial 0 en Intracoronary infusion of selected and unselected mononuclear cells does not lead to significant improvement in cardiac function after sustained ischemia: Results from the REGENT trial Intravenous iron for treatment of anemia in heart failure 0 en Intravenous iron for treatment of anemia in heart failure It’s About Time: A Regionalized Approach to Patients with AMI. August 8, 2007 0 en It’s About Time: A Regionalized Approach to Patients with AMI. August 8, 2007 JNK in the trunk without extra sugar in the tank 0 en JNK in the trunk without extra sugar in the tank JUPITER Trial Demonstrates Effectiveness of Statin Therapy in Reducing Cardiovascular Events among Healthy Patients 0 en JUPITER Trial Demonstrates Effectiveness of Statin Therapy in Reducing Cardiovascular Events among Healthy Patients June 28, 2007: Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients 0 en June 28, 2007: Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients LDL Cholesterol and its Association with Cancer: July 24, 2007 0 en LDL Cholesterol and its Association with Cancer: July 24, 2007 LV Remodeling Reversed among Patients with Asymptomatic Systolic Dysfunction with Metoprolol 0 en LV Remodeling Reversed among Patients with Asymptomatic Systolic Dysfunction with Metoprolol Lancet Editor Forsees Wikis as the Future for Medical Journals 0 en Lancet Editor Forsees Wikis as the Future for Medical Journals Landmark analysis of the TRITON-TIMI 38 trial demonstrates significant benefit with the loading and maintenance doses of prasugrel 0 en Landmark analysis of the TRITON-TIMI 38 trial demonstrates significant benefit with the loading and maintenance doses of prasugrel Larger Versus Smaller Clinical Safety Databases for Regulatory Approval of Drugs. 0 en Larger Versus Smaller Clinical Safety Databases for Regulatory Approval of Drugs. Left main coronary artery disease: which stent type is preferred for off-label PCI? 0 en Left main coronary artery disease: which stent type is preferred for off-label PCI? Left main stenting is associated with similar rates of death, Q wave myocardial infarction and stroke compared with CABG at 3-year follow-up 0 en Left main stenting is associated with similar rates of death, Q wave myocardial infarction and stroke compared with CABG at 3-year follow-up Long Term Adherence to Clopidogrel and Late Adverse Cardiac Events after Off-Label Use of Sirolimus-Eluting Stents: Results of the MATRIX Registry 0 en Long Term Adherence to Clopidogrel and Late Adverse Cardiac Events after Off-Label Use of Sirolimus-Eluting Stents: Results of the MATRIX Registry Long-term outcomes of off-pump vs. on-pump coronary artery bypass grafts. August 12, 2007 0 en Long-term outcomes of off-pump vs. on-pump coronary artery bypass grafts. August 12, 2007 Loss of adenylyl cyclase gene increases life span and protects the aging heart. August 10th, 2007 0 en Loss of adenylyl cyclase gene increases life span and protects the aging heart. August 10th, 2007 Low-risk Women with Unstable Angina and NSTEMI Might be Better off with Medical Therapy than Invasive Treatment 0 en Low-risk Women with Unstable Angina and NSTEMI Might be Better off with Medical Therapy than Invasive Treatment MC-1 does not reduce cardiovascular and cerebrovascular events in phase 3 MEND-CABG II trial 0 en MC-1 does not reduce cardiovascular and cerebrovascular events in phase 3 MEND-CABG II trial MC-1 does not reduce cardiovascular and cerebrovascular events in the phase 3 MEND-CABG II trial 0 en MC-1 does not reduce cardiovascular and cerebrovascular events in the phase 3 MEND-CABG II trial MEND-CABG II trial does not suggest improved outcomes with the novel drug MC1 in patients undergoing high risk coronary artery bypass surgery 0 en MEND-CABG II trial does not suggest improved outcomes with the novel drug MC1 in patients undergoing high risk coronary artery bypass surgery Making the most of cardiac resynchronization therapy : remotely monitoring patients 0 en Making the most of cardiac resynchronization therapy : remotely monitoring patients Measuring Fractional Flow Reserve During PCI Improves 1-Year Outcomes 0 en Measuring Fractional Flow Reserve During PCI Improves 1-Year Outcomes Metabolic syndrome linked to higher rates of atrial fibrillation 0 en Metabolic syndrome linked to higher rates of atrial fibrillation Metabolic syndrome: Study links soft drink consumption with increased risk of developing metabolic syndrome 0 en Metabolic syndrome: Study links soft drink consumption with increased risk of developing metabolic syndrome Metoprolol Associated with Lower Rates of Major CV Events in POISE Trial for High Risk Patients Undergoing Noncardiac Surgery 0 en Metoprolol Associated with Lower Rates of Major CV Events in POISE Trial for High Risk Patients Undergoing Noncardiac Surgery Microvolt T Wave Alternans Test (MTWA) not Predictive of Ventricular Arrhythias Following MI 0 en Microvolt T Wave Alternans Test (MTWA) not Predictive of Ventricular Arrhythias Following MI More evidence of the primacy of chest compressions over ventilation in cardiopulmonary resuscitation 0 en More evidence of the primacy of chest compressions over ventilation in cardiopulmonary resuscitation Myeloperoxidase levels shown to predict future cardiovascular risk in healthy individuals. July 11, 2007 0 en Myeloperoxidase levels shown to predict future cardiovascular risk in healthy individuals. July 11, 2007 NHLBI recommends early termination of the intensive blood sugar lowering strategy in the ACCORD trial 0 en NHLBI recommends early termination of the intensive blood sugar lowering strategy in the ACCORD trial NOBORI™ stent is non-inferior to Taxus® stents in the NOBORI 1 trial 0 en NOBORI™ stent is non-inferior to Taxus® stents in the NOBORI 1 trial Nephrotic syndrome and risk of venous and arterial thromboembolism 0 en Nephrotic syndrome and risk of venous and arterial thromboembolism New AHA statement focuses on improving rates and success of bystander CPR 0 en New AHA statement focuses on improving rates and success of bystander CPR New AHA statement on hyperglycemia during ACS admissions 0 en New AHA statement on hyperglycemia during ACS admissions New formula for predicting long-term survival based on exercise treadmill testing 0 en New formula for predicting long-term survival based on exercise treadmill testing New guidelines for the management of cocaine chest pain 0 en New guidelines for the management of cocaine chest pain New guidelines hope to clarify the role of endomyocardial biopsies 0 en New guidelines hope to clarify the role of endomyocardial biopsies New meta-analysis demonstrates significant incidence of psychiatric side effects of the weight loss medication rimonabant 0 en New meta-analysis demonstrates significant incidence of psychiatric side effects of the weight loss medication rimonabant New practice guidelines for use of biomarkers in ACS and heart failure. July 22, 2007 0 en New practice guidelines for use of biomarkers in ACS and heart failure. July 22, 2007 New randomized comparison of unprotected left main coronary artery stenting and CABG 0 en New randomized comparison of unprotected left main coronary artery stenting and CABG New study uses gene variants to predict cardiovascular risk 0 en New study uses gene variants to predict cardiovascular risk New target for treating salt-induced hypertension 0 en New target for treating salt-induced hypertension Obesity without insulin resistance: altered fatty acid metabolism in the liver associated with protection from insulin resistance 0 en Obesity without insulin resistance: altered fatty acid metabolism in the liver associated with protection from insulin resistance One third of deaths following coronary artery bypass surgery are preventable 0 en One third of deaths following coronary artery bypass surgery are preventable Ongoing Search for Improved CRT Optimization Technique 0 en Ongoing Search for Improved CRT Optimization Technique PCI: Nonclinical factors may influence physician decision-making 0 en PCI: Nonclinical factors may influence physician decision-making PEPCAD II ISR study suggests that drug eluting balloons are safe and effective compared with drug eluting stents in treating in-stent restenosis 0 en PEPCAD II ISR study suggests that drug eluting balloons are safe and effective compared with drug eluting stents in treating in-stent restenosis PROVIDENCE-1 trial Results: Rifalazil Has No Effect in Patients with Intermittent Claudication 0 en PROVIDENCE-1 trial Results: Rifalazil Has No Effect in Patients with Intermittent Claudication PRoFESS®, the Largest Recurrent Stroke Prevention Trial Results were Presented at the 17th European Stroke Conference 0 en PRoFESS®, the Largest Recurrent Stroke Prevention Trial Results were Presented at the 17th European Stroke Conference Paclitaxel coated angioplasty balloons are effective in reducing restenosis in the leg 0 en Paclitaxel coated angioplasty balloons are effective in reducing restenosis in the leg Paclitaxel eluting stents are safe and effective in diabetic patients compared to bare metal stents 0 en Paclitaxel eluting stents are safe and effective in diabetic patients compared to bare metal stents Panic Attacks in Postmenopausal Women Increase Risk of CV Events 0 en Panic Attacks in Postmenopausal Women Increase Risk of CV Events Percutaneous Coronary Interventions can be performed in centers without on-site cardiac surgical back-up 0 en Percutaneous Coronary Interventions can be performed in centers without on-site cardiac surgical back-up Periostin: A possible treatment for heart failure. July 20, 2007 0 en Periostin: A possible treatment for heart failure. July 20, 2007 Pioglitazone Prevents Progression of Coronary Atherosclerosis in Diabetic Patients With Coronary Artery Disease: Results of the PERISCOPE Trial 0 en Pioglitazone Prevents Progression of Coronary Atherosclerosis in Diabetic Patients With Coronary Artery Disease: Results of the PERISCOPE Trial Planning your New Year’s resolution—which diet is best? 0 en Planning your New Year’s resolution—which diet is best? Platelet monitoring can improve outcomes following PCI among clopidogrel resistant patients 0 en Platelet monitoring can improve outcomes following PCI among clopidogrel resistant patients Pre Treatment with 600 mg of Clopidogrel does not Improve Outcomes in Stable PCI Patients: PRAGUE-8 0 en Pre Treatment with 600 mg of Clopidogrel does not Improve Outcomes in Stable PCI Patients: PRAGUE-8 Pre-operative Statin Therapy Improves Clinical Outcomes among Cardiac Surgical Patients: Results from a Meta-Analysis 0 en Pre-operative Statin Therapy Improves Clinical Outcomes among Cardiac Surgical Patients: Results from a Meta-Analysis Predicting the Mode of Death for Heart Failure Patients. July 29, 2007 0 en Predicting the Mode of Death for Heart Failure Patients. July 29, 2007 Predicting who will benefit from cardiac resynchronization therapy: results of PROSPECT 0 en Predicting who will benefit from cardiac resynchronization therapy: results of PROSPECT Preoperative statins for prevention of atrial fibrillation following cardiac surgery 0 en Preoperative statins for prevention of atrial fibrillation following cardiac surgery Prevention: Results of the ILLUMINATE Trial Released at AHA 2007 0 en Prevention: Results of the ILLUMINATE Trial Released at AHA 2007 Promising results from a phase 2 study of a vaccine for hypertension 0 en Promising results from a phase 2 study of a vaccine for hypertension Pulmonary embolism is the cause of approximately 10% of hospital deaths despite approved therapies for treatment and prevention. July 26, 2007 0 en Pulmonary embolism is the cause of approximately 10% of hospital deaths despite approved therapies for treatment and prevention. July 26, 2007 INST 102 en INST